广西部分地区猪流感病毒的血清学调查

为了解广西猪群中猪流感(SI)的流行情况,以猪流感病毒H3N2亚型作为诊断抗原,采用微量血凝抑制试验(HI)方法,对广西部分市(县)的猪群进行猪流感的血清学调查.在12个市(县)采集的1000份血清中,有10个市(县)检出H3N2抗体,共有257份血清呈H3N2抗体阳性,平均阳性率为25.7%.百色的阳性率最高,达到82.9%,贵港和南宁市郊两地没有检出阳性,其它9个市(县)的阳性率在13.0%～45.7%之间.结果表明我区猪群中很可能存在H3N2亚型猪流感感染,其中百色地区猪流感的感染率比较高.     

2016年我国部分地区屠宰场猪流感血清学调查

目前,全球范围内流行的猪流感病毒亚型主要有3种:H1N1、H3N2、H1N2,此外,H1N7、H4N6、H9N2、H5N1、H3N3、H3N1和H2N3等亚型病毒也在猪体内分离到,但没有证据显示这些病毒在猪体内建立稳定的谱系。为了解我国屠宰场猪群中流感病毒的感染与流行情况,选取2009年甲型H1N1(pdm/09)、欧洲类禽H1N1(EA H1)、经典H1N1(经典H1)、新型三源重排H1N1(ReH1)、H3N2(H3)、H9N2(H9)流感病毒制备的血凝抑制(HI)标准抗原作为检测抗原,对全国25个屠宰场的猪血清进行了HI抗体的检测。结果显示,2016年我国屠宰场样品中,pdm/09、EA H1、经典H1、Re H1、H3、H9抗体阳性率分别为23.18%、28.12%、19.34%、24.97%、7%、7.41%;在所监测地区中,华南地区屠宰场猪流感血清平均抗体阳性率最高。结果表明,2016年我国屠宰场猪群中H1N1亚型猪流感病毒感染比较普遍,H3N2和H9N2亚型猪流感病毒抗体阳性率较低。     

甘肃省猪流感(H3N2)抗体的血清学调查研究

用酶联免疫吸附试验(ELISA)对甘肃省13个市州送检的188份健康猪血清和17个猪场患其它病猪血清进行了猪流感(H3N2)血清抗体检测.在11个市州的猪群中检出SIH3N2抗体,检出阳性118份,平均阳性率为27.89%.阳性率最高为66.67%,最低为5.13%.其中健康猪血清检出阳性42份,阳性率为22.34%;患其它病猪血清检出阳性76份,阳性率为32.34%.患其它病猪的阳性率高于健康猪.     

甘肃省猪流感H5和H9抗体的血清学调查

用血凝（HA）和血凝抑制试验（HI）对甘肃省742份猪血清进行了猪流感H5和H9亚型抗体检测。在12个市州的猪群中检出SIH9亚型抗体,检出阳性34份,平均阳性率为4．58％。阳性率最高为9．09％,最低为0．91％。在2个市州的猪群中检出SIH5亚型抗体,检出阳性3份,平均阳性率为0．40％。阳性率最高为4．76％,最低为2．98％。检测患病猪（非流感病）血清66份,其中8份检测出SIH9抗体．抗体阳性率为12．12％。     

河南省部分地区猪流感血清学调查

采用血凝抑制试验对河南省新乡、焦作、漯河等地采集的139份猪血清样品进行了猪流感病毒H1、H3、H5、H9亚型抗体的检测.结果显示,在被调查的139份血清中,H1亚型SIV抗体阳性率为43.17%,H3亚型SIV抗体阳性率为0,H5亚型SIV抗体阳性率为2.16%.H9亚型SIV抗体阳性率为1.44%:H1+H5亚型SIV抗体阳性率为1.44%;H1+H9亚型SIV抗体阳性率为1.44%:H1+H5+H9亚型SIV抗体阳性率为0.表明在所调查的猪群中,猪流感病毒的感染较为普遍,大部分猪场都曾被H1亚型感染,部分猪群有多种亚型混合感染存在.     

天津地区猪流感血清学调查

2002年-2005年期间,采用血凝抑制试验对天津市10个区县44个养猪场进行了猪流感病毒抗体检测,结果75%的被调查猪场抗体检测结果有阳性,检测的648份血清样品中,69.6%为阳性。流感病毒抗体亚型调查结果显示该地区流行的猪流感病毒主要为H1和H3亚型,抗体阳性率分别为55.4%和39.4%。部分猪群中存在抗H9亚型流感病毒抗体,阳性率为5.4%,但未发现H5亚型流感病毒抗体。此外,部分猪群中同时存在2种或3种亚型(H1,H3和H9)流感病毒的抗体,表明这些猪曾经同时被2种或3种不同亚型的流感病毒感染。     

河南省部分地区猪流感血清学调查

采用血凝抑制试验对河南省新乡、焦作、漯河等地采集的139份猪血清样品进行了猪流感病毒H1、H3、H5、H9亚型抗体的检测。结果显示,在被调查的139份血清中,H1亚型SIV抗体阳性率为43．17％,H3亚型SIV抗体阳性率为0,H5亚型SIV抗体阳性率为2．16％,H9亚型SIV抗体阳性率为1．44％;H1＋H5亚型SIV抗体阳性率为1．44％：H1＋H9亚型SIV抗体阳性率为1．44％;H1＋H5＋H9亚型SIV抗体阳性率为0。表明在所调查的猪群中,猪流感病毒的感染较为普遍,大部分猪场都曾被H1亚型感染,部分猪群有多种亚型混合感染存在。     

宁夏猪流感血清学调查

采用血凝抑制试验对宁夏22个县(区、市)43个规模猪场、10个屠宰场、197个散养户的1710份猪血清样品进行了猪流感病毒H1、H3亚型抗体的检测。结果显示,被调查的样品中,H1亚型抗体阳性率为11.81%,H3亚型抗体阳性率为0.46%,H1+H3亚型抗体阳性率为0.35%。表明在所调查的宁夏猪场中,猪流感病毒的感染较为普遍,大部分猪场都曾被H1、H3亚型感染。     

2019～2022年辽宁省规模场猪流感血清流行病学调查

为了解和掌握最近几年时间里辽宁省规模化猪场猪流感的感染和流行情况,本试验利用血凝抑制试验对2019年3月～2022年6月期间在辽宁省沈阳、大连、本溪和铁岭四个城市的规模化猪场采集的572份猪血清样本进行了抗体检测。结果显示,调查期间内,猪流感抗体阳性血清总数为304份,总血清阳性率达53.15%;2019～2022不同年份时间内,2009年甲型H1N1(pdm/09H1N1)年平均抗体阳性率分别为8.15%、12.30%、18.56%和16.22%,欧洲类禽型H1N1(EA H1N1)年平均抗体阳性率分别为17.04%、23.77%、13.17%和19.59%,经典H1N1(CS H1N1)年平均抗体阳性率则分别为20.00%、26.23%、21.56%和20.98%;四个城市中沈阳规模化猪场中猪的抗体阳性率最高,达到72.09%,沈阳的猪场以EA H1N1亚型猪流感为主,本溪和铁岭的猪场以CS H1N1亚型为主,大连猪场则主要是pdm/09 H1N1亚型;不同生长阶段的猪样本中仔猪的血清阳性率最高（78.65%）,其次是保育猪（58.97%）,而育肥猪的阳性率最低（37.61%）。本...     

2011年～2012年我国不同地区猪流感血清学监测

为了解猪流感病毒(SIV)在我国的流行情况,本研究对2011年～2012年从不同省市重点地区屠宰场、规模化猪场和个体养殖户采集猪血清样品13044份,以经典H1N1 (CS)、类禽H1N1 (EA)、甲型H1N1(pdm/09)、H3N2、H5N1、H9N2亚型SIV抗原并采用血凝抑制(HI)方法检测.结果显示,2011年～2012年我国猪血清中类禽H1N1亚型SIV抗体平均阳性率比其他亚型高,分别为42.24％和45.89％,2011年甲型H1N1亚型SIV血清抗体平均滴度(GMT)比其他亚型高,GMT为53.32,2012年经典H1N1 GMT比其他亚型高,GMT为73.2.结果表明2011年～2012年我国猪群中H1N1亚型SIV感染较为普遍.     

Seroprevalence of porcine and human influenza A virus antibodies in pigs between 1986 and 1988 in Hassia

1,268 sera collected from slaughtered pigs in Hassia (FRG) from 1986 to 1988 were tested for antibodies against porcine and human influenza A virus strains using the single radial haemolysis test (SRHT). Antibodies against the porcine strains (subtype H1N1) A/Swine/Arnsberg/1/81, A/Swine/Iowa/15/30 and A/New Jersey/7/76 were detected in 411 (32.4%), 318 (25.1%) and 304 (24.0%) of sera, respectively. Up to 1988 a slight increase (10%) in the seroprevalence to A/Swine/Arnsberg/1/81 was noticed, whereas the results obtained with the other strains showed little variation. Antibodies against the human H1N1 strain A/Singapore/6/86 were only found in sera collected 1987 and 1988 in rates of 1.6% and 3.0%. Serological indication of infections with the human H3N2 strains A/Victoria/1/75, A/Hong Kong/1/68 and A/Philippines/2/82 could be shown in 286 (22.6%), 178 (14.4%) and 135 (10.6%) of the serum samples. Within the three year period the rate of sera positive for antibodies against A/Philippines/2/82 increased from 6.5% to 23.0%, whereas no variation in the rates were found using the other H3N2 strains. Antibodies simultaneously against porcine (H1N1) and human (H3N2) virus strains were detected in 9.9% of all sera tested.     

Comparison of a commercial enzyme-linked immunosorbent assay with hemagglutination inhibition assay for serodiagnosis of swine influenza virus (H1N1) infection.

A commercial indirect swine influenza virus (SIV) H1N1 enzyme-linked immunosorbent assay (ELISA) was compared with the hemagglutination inhibition (HI) assay by testing 72 samples from experimentally infected pigs and 780 field samples of undefined SIV status. The HI assay was performed using SIV isolates A/Swine/IA/73 for H1N1 and A/Swine/IA/8548-1/98 for H3N2. The ELISA used an SIV isolated in 1988. The results showed that HI and ELISA detected an antibody in 11 and 6, respectively, of 72 serum samples collected from pigs experimentally infected with a 1992 SIV isolate (A/Swine/IA/40776/92). The presence of antibodies in these experimental samples was confirmed by HI tests in which all 72 samples were positive against the homologous virus, a more recent H1N1 SIV isolate (A/Swine/NVSL/01) supplied by National Veterinary Services Laboratories, Ames, Iowa, and a 1999 H1N1 isolate currently used in a commercial vaccine. On testing 780 field samples, an overall agreement of 85.5% was generated between the HI and ELISA. This study demonstrated that the ELISA is a useful serodiagnostic screening test at herd level for detecting swine antibodies against SIV. However, a new SIV isolate representing current SIV strains circulating in the field is needed to replace the older isolates used in the HI and ELISA to increase the test accuracy for serodiagnosis of SIV.     

Evidence of pandemic H1N1 influenza exposure in dogs and cats,Thailand: A serological survey

Influenza A virus causes respiratory disease in both humans and animals. In this study, a survey of influenza A antibodies in domestic dogs and cats was conducted in 47 animal shelters in 19 provinces of Thailand from September 2011 to September 2014. One thousand and eleven serum samples were collected from 932 dogs and 79 cats. Serum samples were tested for influenza A antibodies using a multi‐species competitive NP‐ELISA and haemagglutination inhibition (HI) assay. The NP‐ELISA results showed that 0.97% (9/932) of dogs were positive, but all cat samples were negative. The HI test against pandemic H1N1, human H3N2 and canine H3N2 showed that 0.64% (6/932) and 1.20% (1/79) of dogs and cats were positive, respectively. It is noted that all six serum samples (5 dogs and 1 cat) had antibodies against pandemic H1N1. In summary, a serological survey revealed the evidence of pandemic H1N1 influenza exposure in both dogs and cats in the shelters in Thailand.     

Seroprevalence and risk factors for influenza A viruses in pigs in Peninsular Malaysia

Following a series of H5N1 cases in chickens and birds in a few states in Malaysia, there was much interest in the influenza A viruses subtypes that circulate among the local pig populations. Pigs may act as a mixing vessel for avian and mammal influenza viruses, resulting in new reassorted viruses. This study investigated the presence of antibodies against influenza H1N1 and H3N2 viruses in pigs from Peninsular Malaysia using Herdcheck Swine Influenza H1N1 and H3N2 Antibody Test Kits. At the same time, the presence of influenza virus was examined from the nasal swabs of seropositive pigs by virus isolation and real time RT-PCR. The list of pig farms was obtained from the headquarters of the Department of Veterinary Services, Malaysia, and pig herds were selected randomly from six of 11 states in Peninsular Malaysia. A total of 727 serum and nasal swab samples were collected from 4- to 6-month-old pigs between May and August 2005. By ELISA, the seroprevalences of swine influenza H1N1 and H3N2 among pigs were 12.2% and 12.1% respectively. Seropositivity for either of the virus subtypes was detected in less than half of the 41 sampled farms (41.4%). Combination of both subtypes was detected in 4% of all pigs and in 22% of sampled farms. However, no virus or viral nucleic acid was detected from nasal samples. This study identified that the seropositivity of pigs to H1N1 and H3N2 based on ELISA was significantly associated with factors such as size of farm, importation or purchase of pigs, proximity of farm to other pig farms and the presence of mammalian pets within the farm.     

Streptococcus suis type 2 culture supernatant enhances the infection ability of the Swine influenza virus H3 subtype in MDCK cells

Swine Influenza virus and Streptococcus suis type 2 often occur as a clinical coinfection in pigs, the syndrome of which is more serious than the virus or bacterium sole infection. Streptococcus suis type 2 can produce extracellular proteases, which may cleave hemagglutinin to enhance the infection ability of Swine Influenza virus. The current study investigated whether extracellular proteolytic culture supernatant of Streptococcus suis type 2, isolated from Jiangsu, enhanced the infection ability of H3N2 Swine Influenza virus (A/Swine/Guangdong/4/2003) on MDCK cells. Our data suggested that exposure of MDCK cells to culture supernatant of Streptococcus suis type 2 enhanced the cytopathic effect produced by Swine Influenza virus, hemagglutination of cell culture supernatants and FITC immunofluorescence intensity.     

Prevalence and incidence of Newcastle disease and prevalence of Avian Influenza infection of scavenging village chickens in Timor-Lesté

A longitudinal study to monitor prevalence and incidence of antibodies against Newcastle disease (ND) virus and prevalence of antibodies against Avian Influenza (AI) virus in scavenging village chickens was conducted in 20 villages within 4 districts of Timor-Lesté. A total of 3600 blood samples was collected from 1674 individual birds in 300 household chicken flocks during three sampling periods (December 2008-February 2009, March-May 2009, and June-August 2009). The mean interval between household visits was 101.6±1.9 days. None of the birds enrolled in the study was vaccinated against ND or AI. A haemagglutination inhibition (HI) test was used to determine antibody titres against ND virus and a competitive ELISA and HI tests were used to detect antibody against AI virus. The bird-level ND seroprevalence pooled across all samplings (adjusted for clustering by households) was 4.4% (95% CI 3.5-5.2). The bird-level ND seroprevalence in each of the three sampling periods (adjusted for clustering by household) was 3.0% (95% CI 2.0-4.0), 6.6% (95% CI 5.1-8.0) and 3.6 (95% CI 2.5-4.6), respectively. A total of 12.6% individual birds tested ND seropositive at least once over the total study period (95% CI 10.5-14.7). The flock-level ND seroprevalence (at least one bird tested had antibodies against ND virus) pooled across all samplings was 15.9% (95% CI 13.5-18.3). A total of 35.3% flocks had a minimum of one bird being ND seropositive at least once over the study period. The bird-level incidence rate for the period between the first and the second sampling and between the second and the third sampling was 5.6 (95% CI 4.1-7.5) and 0.5 (95% CI 0.5-3.8) per 10,000 bird-years-at-risk, respectively. A total of 1134 serum samples from the last sampling period between June and August 2009 was tested for antibodies against AI virus. Only 4 samples tested Influenza A positive, indicating a bird-level seroprevalence level for Influenza A of 0.4% (CI 0.0-0.7%). These Influenza A positive samples were further tested for HI antibodies against AI virus subtypes of H5N1, H5N3, H7N3 and H9N2, but all tested negative, suggesting that the influenza antibodies in those four birds resulted from exposure to low pathogenic AI viruses of different H subtypes. Our results indicate that village chickens in Timor-Lesté are exposed to ND virus; there was a higher risk of infection during the early months of 2009 than either immediately prior or subsequent to this. No evidence of infection of village chickens with H5, H7 or H9 AI viruses was detected in this study.     

Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge

Influenza A (H1N1) virus has caused human influenza outbreaks in a worldwide pandemic since April 2009. Pigs have been found to be susceptible to this influenza virus under experimental and natural conditions, raising concern about their potential role in the pandemic spread of the virus. In this study, we generated a high-growth reassortant virus (SC/PR8) that contains the hemagglutinin (HA) and neuraminidase (NA) genes from a novel H1N1 isolate, A/Sichuan/1/2009 (SC/09), and six internal genes from A/Puerto Rico/8/34 (PR8) virus, by genetic reassortment. The immunogenicity and protective efficacy of this reassortant virus were evaluated at different doses in a challenge model using a homologous SC/09 or heterologous A/Swine/Guangdong/1/06(H1N2) virus (GD/06). Two doses of SC/PR8 virus vaccine elicited high-titer serum hemagglutination inhibiting (HI) antibodies specific for the 2009 H1N1 virus and conferred complete protection against challenge with either SC/09 or GD/06 virus, with reduced lung lesions and viral shedding in vaccine-inoculated animals compared with non-vaccinated control animals. These results indicated for the first time that a high-growth SC/PR8 reassortant H1N1 virus exhibits properties that are desirable to be a promising vaccine candidate for use in swine in the event of a pandemic H1N1 influenza.     

Exposure of domestic swine to influenza A viruses in Ghana suggests unidirectional,reverse zoonotic transmission at the human–animal interface

Influenza A viruses (IAVs) have both zoonotic and anthroponotic potential and are of public and veterinary importance. Swine are intermediate hosts and ‘mixing vessels’ for generating reassortants, progenies of which may harbour pandemic propensity. Swine handlers are at the highest risk of becoming infected with IAVs from swine but there is little information on the ecology of IAVs at the human–animal interface in Africa. We analysed and characterized nasal and throat swabs from swine and farmers respectively, for IAVs using RT‐qPCR, from swine farms in the Ashanti region, Ghana. Sera were also analysed for IAVs antibodies and serotyped using ELISA and HI assays. IAV was detected in 1.4% (n = 17/1,200) and 2.0% (n = 2/99) of swine and farmers samples, respectively. Viral subtypes H3N2 and H1N1pdm09 were found in human samples. All virus‐positive swine samples were subtyped as H1N1pdm09 phylogenetically clustering closely with H1N1pdm09 that circulated among humans during the study period. Phenotypic markers that confer sensitivity to Oseltamivir were found. Serological prevalence of IAVs in swine and farmers by ELISA was 3.2% (n = 38/1,200) and 18.2% (n = 18/99), respectively. Human H1N1pdm09 and H3N2 antibodies were found in both swine and farmers sera. Indigenous swine influenza A viruses and/or antibodies were not detected in swine or farmers samples. Majority (98%, n = 147/150) of farmers reported of not wearing surgical mask and few (4%, n = 6) reported to wear gloves when working. Most (n = 74, 87.7%) farmers reported of working on the farm when experiencing influenza‐like illness. Poor husbandry and biosafety practices of farmers could facilitate virus transmission across the human–swine interface. Farmers should be educated on the importance of good farm practices to mitigate influenza transmission at the human–animal interface.     

First report of seroprevalence of swine influenza a virus in Tibetan pigs in Tibet, China

Swine influenza A virus (SIV) is zoonotic pathogen that can be acquired by food-borne transmission because food animals, for example pigs, are recognized as a reservoir. The objectives of this study were to determine the seroprevalence of anti-SIV (H1N1 and H3N2) in Tibetan pigs in Tibet Nationality Autonomous Region, China, a region with cold weather and high altitude. A total of 421 serum samples were randomly collected from Tibetan pigs in Tibet and were evaluated for antibodies against SIV using enzyme-linked immunosorbent assay. Overall, 52 % (219/421) of the animals was positive for H1N1, 16.9 % (71/421) positive for H3N2, and 8.8 % (37/421) positive for both H1N1 and H3N2. The results of the present survey indicated that SIV is highly prevalent among Tibetan pigs in Tibet, China. The results of the present investigation have implications for the ongoing control of SIV infection in Tibetan pigs in Tibet, China and elsewhere.     

Analysis of the situation of swine influenza in the districts Upper Bavaria, Swabia, Freiburg and Tübingen based on antibody profiles of piglets from Bavarian breeding farms

A total of 1026 serum samples from 388 pigs from three Bavarian rearing farms in the region of Swabia were investigated in the course of investigations into the development of antibodies against Influenza A virus subtypes H1N1, H1N2 and H3N2 by haemagglutination inhibition test during the period from November 2002 to February 2004. There were no signs of respiratory disease during this period. The antibody titres decreased steadily in this period which corresponds to the kinetics of maternally-derived antibodies. Therefore the antibodies reflect the situation of influenza in the farms of origin from which the piglets were purchased. These farms were located in Bavaria and Baden-Wuerttemberg. There was a high activity of H1N1 influenza A viruses in this region whereas the antibody profiles against H1N2 and H3N2 varied between the different farms, which can be attributed to past vaccinations and infections. Thus there was a uniform immunological situation within the regions against H1N1 whereas that against H1N2 and H3N2 differed. The analysis of the antibody profiles allows conclusions to be drawn about the epidemiological situation and means of immunoprophylaxis.